Generics
We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.
Anhydrous form R1
Therapeutic Area
Oncology
Status
Pipeline
CAS No.
915087-33-1
Reference Product